RxSight, Inc. RXST Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$15.88M-73.6% | -$9.15M+6.8% | -$9.82M+16.7% | -$11.79M-43.9% | -$8.19M-37.9% | ||
| $834K-2.0% | $851K-0.4% | $854K+8.8% | $785K+1.2% | $776K+50.7% | ||
| $7.95M+1.6% | $7.82M-3.6% | $8.11M-5.1% | $8.55M+19.7% | $7.14M-2.0% | ||
| -$936K-18.8% | -$788K+79.8% | -$3.91M-35.3% | -$2.89M-411% | $928K-80.2% | ||
| $3.37M+4.5% | $3.23M-18.5% | $3.96M+46.2% | $2.71M+69.4% | $1.6M+291% | ||
| $1.58M-28.4% | $2.2M+2,663% | -$86K+97.7% | -$3.72M-267% | $2.23M+1,819% | ||
| -$1.26M— | —— | —— | —— | -$6.16M-277% | ||
| -$120K— | —— | -$322K+78.4% | -$1.49M-486% | -$254K-113% | ||
| $0— | —— | $0+100% | -$9K-200% | $9K+12.5% | ||
| —— | $0— | $0— | $0— | $0— | ||
| -$10.89M-876% | -$1.12M+6.0% | -$1.19M+72.9% | -$4.38M+50.5% | -$8.83M-107% | ||
| $759K-33.2% | $1.14M+95.7% | $581K-62.2% | $1.54M+167% | $575K-32.1% | ||
| $100.39M+1.9% | $98.48M+43.9% | $68.42M+102% | $33.81M-12.3% | $38.57M-27.0% | ||
| $110M+22.2% | $90M+50.0% | $60M+20.0% | $50M-16.7% | $60M+9.1% | ||
| $8.85M— | —— | —— | $14.65M-29.7% | $20.86M— | ||
| $144K-86.4% | $1.06M+706% | $131K-93.7% | $2.07M+197% | $696K-76.7% | ||
| $7K— | —— | $19K+533% | $3K-76.9% | $13K+8.3% | ||
| —— | $0— | $0— | $0— | $0— | ||
| -$336K-132% | $1.06M— | —— | $2.07M+381% | -$735K-125% | ||
| $3K— | —— | —— | $14K+133% | $6K+150% | ||
| -$2.38M— | —— | —— | $12.36M+9.4% | $11.29M+46,958% | ||
| $0— | —— | —— | $67K+2,133% | $3K— | ||
| $1.85M+1.2% | $1.83M-14.6% | $2.14M+0.7% | $2.13M-11.7% | $2.41M-8.3% | ||
| -$1.26M— | —— | —— | —— | -$6.16M-277% | ||
| -$120K— | —— | -$322K+78.4% | -$1.49M-486% | -$254K-113% | ||
| $60K-90.3% | $616K+833% | $66K-94.6% | $1.22M+3,832% | $31K-56.3% | ||
| $0— | —— | $0+100% | -$9K-200% | $9K+12.5% | ||
| —— | —— | —— | —— | —— | ||
| $0— | —— | —— | $11K-47.6% | $21K— | ||
| $100.39M+1.9% | $98.48M+43.9% | $68.42M+102% | $33.81M-12.3% | $38.57M-27.0% | ||
| $110M+22.2% | $90M+50.0% | $60M+20.0% | $50M-16.7% | $60M+9.1% | ||
| $7K— | —— | $19K+533% | $3K-76.9% | $13K+8.3% | ||
| -$473K-23,550% | -$2K+99.7% | -$642K— | $0+100% | -$1.42M— | ||
| —— | $0— | $0— | —— | —— | ||
| —— | $0— | $0— | —— | —— | ||
| $170K-40.6% | $286K— | —— | $46K-77.5% | $204K+34.2% | ||
| $980K+43.3% | $684K+22.1% | $560K-18.7% | $689K-0.7% | $694K+33.2% | ||
| —— | $0— | $0— | $0— | $0— | ||
| —— | —— | —— | —— | —— | ||
| $0— | —— | —— | $67K+2,133% | $3K— | ||
| -$11.65M-417% | -$2.25M-27.4% | -$1.77M+70.1% | -$5.91M+37.1% | -$9.41M-84.2% | ||
| -$11.65M-417% | -$2.25M-27.4% | -$1.77M+70.1% | -$5.91M+37.1% | -$9.41M-84.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does RxSight, Inc. generate?
- RxSight, Inc. (RXST) generated -$17.6M in operating cash flow over the trailing twelve months.
- What is RxSight, Inc.'s free cash flow?
- After $4.0M of capital expenditures, RxSight, Inc.'s free cash flow was -$21.6M over the trailing twelve months, down 5.2% year over year.
- Where does RxSight, Inc.'s cash flow data come from?
- Every line is extracted from RxSight, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
